Betta Pharmaceuticals Co., Ltd.
SZSE:300558.SZ
56.19 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 838.753 | 760.245 | 730.664 | 412.386 | 729.673 | 782.259 | 531.619 | 713.912 | 409.381 | 668.631 | 584.706 | 521.436 | 569.267 | 536.591 | 618.562 | 362.544 | 555.838 | 304.806 | 647.079 | 310.481 | 481.455 | 387.147 | 374.841 | 296.581 | 346.255 | 296.721 | 284.615 | 258.083 | 270.136 | 268.599 | 229.54 | 247.701 | 268.784 | 243.649 | 274.927 | 200.102 |
| Cost of Revenue
| 137.411 | 154.747 | 128.544 | 152.589 | 85.698 | 129.36 | 78.258 | 78.764 | 51.162 | 68.329 | 70.439 | 49.921 | 40.222 | 44.938 | 39.356 | 33.281 | 37.847 | 21.709 | 46.061 | 24.856 | 38.121 | 20.061 | 22.19 | 27.014 | 15.862 | 13.429 | 12.684 | 11.493 | 10.177 | 12.592 | 9.44 | 9.267 | 8.097 | 7.564 | 7.902 | 6.8 |
| Gross Profit
| 701.342 | 605.498 | 602.121 | 259.797 | 643.975 | 652.899 | 453.36 | 635.148 | 358.219 | 600.302 | 514.266 | 471.515 | 529.045 | 491.653 | 579.206 | 329.263 | 517.99 | 283.097 | 601.018 | 285.625 | 443.334 | 367.086 | 352.651 | 269.567 | 330.393 | 283.292 | 271.931 | 246.59 | 259.959 | 256.007 | 220.1 | 238.434 | 260.687 | 236.085 | 267.025 | 193.302 |
| Gross Profit Ratio
| 0.836 | 0.796 | 0.824 | 0.63 | 0.883 | 0.835 | 0.853 | 0.89 | 0.875 | 0.898 | 0.88 | 0.904 | 0.929 | 0.916 | 0.936 | 0.908 | 0.932 | 0.929 | 0.929 | 0.92 | 0.921 | 0.948 | 0.941 | 0.909 | 0.954 | 0.955 | 0.955 | 0.955 | 0.962 | 0.953 | 0.959 | 0.963 | 0.97 | 0.969 | 0.971 | 0.966 |
| Reseach & Development Expenses
| 127.758 | 89.651 | 152.75 | 158.73 | 133.422 | 159.162 | 175.356 | 217.989 | 164.842 | 209.434 | 107.64 | 200.416 | 122.844 | 124.359 | 118.329 | 96.071 | 95.356 | 81.765 | 89.659 | 81.663 | 83.607 | 94.321 | 66.772 | 117.731 | 67.987 | 211.731 | 54.438 | 258.336 | 56.734 | 90.39 | 0 | 161.503 | 0 | 73.736 | 0 | 119.944 |
| General & Administrative Expenses
| 0 | 14.982 | 114.726 | -159.078 | 162.354 | 27.994 | 101.818 | -112.284 | 199.501 | 96.482 | 133.075 | -11.93 | 141.846 | -0.645 | 63.695 | -61.717 | 57.78 | -14.035 | 84.947 | -57.636 | 61.841 | -8.263 | 66.105 | -25.318 | 44.467 | -66.224 | 93.046 | -156.739 | 86.953 | -40.803 | 61.587 | -131.033 | 60.378 | -54.938 | 64.611 | -94.831 |
| Selling & Marketing Expenses
| 0 | 293.223 | 230.483 | 144.37 | 251.603 | 303.788 | 154.125 | 288.874 | 49.853 | 259.687 | 180.644 | 149.627 | 219.876 | 209.942 | 235.274 | 102.6 | 212.332 | 110.761 | 258.312 | 93.542 | 172.428 | 147.347 | 149.671 | 102.266 | 138.327 | 136.373 | 119.387 | 87.543 | 105.226 | 107.717 | 93.401 | 105.356 | 94.58 | 90.458 | 108.183 | 76.896 |
| SG&A
| 430.145 | 360.735 | 340.135 | 86.914 | 413.958 | 331.781 | 255.943 | 176.589 | 249.354 | 356.169 | 313.719 | 137.697 | 361.722 | 209.297 | 298.969 | 40.883 | 270.111 | 96.726 | 343.259 | 35.907 | 234.269 | 139.084 | 215.776 | 76.947 | 182.793 | 70.149 | 212.433 | -69.195 | 192.18 | 66.914 | 154.988 | -25.677 | 154.958 | 35.52 | 172.793 | -17.935 |
| Other Expenses
| 0 | -2.676 | -1.132 | -2.757 | -1.007 | 25.128 | -5.619 | 141.953 | -82.865 | 51.544 | -6.824 | -1.227 | -1.41 | -1.984 | -1.051 | -4.396 | -2.758 | -3.68 | -3.171 | 1.05 | 0.069 | -0.068 | -1.159 | -4.902 | 3.16 | 1.499 | 1.921 | 28.712 | 11.4 | 2.403 | 27.141 | 5.137 | 7.927 | 15.65 | 29.843 | 1.463 |
| Operating Expenses
| 557.903 | 450.386 | 492.885 | 245.643 | 472.029 | 563.543 | 425.68 | 536.531 | 331.331 | 617.146 | 414.535 | 461.639 | 406.281 | 411.339 | 410.741 | 246.004 | 363.57 | 247.982 | 431.255 | 237.255 | 314.808 | 305.267 | 279.615 | 260.715 | 239.16 | 244.035 | 216.97 | 167.756 | 197.494 | 195.288 | 159.56 | 173.249 | 159.752 | 127.736 | 177.929 | 133.601 |
| Operating Income
| 143.438 | 155.112 | 109.235 | 14.154 | 150.585 | 81.575 | 4.863 | 0.804 | 18.603 | -16.844 | 97.041 | 12.121 | 124.94 | 85.049 | 173.491 | 67.512 | 425.845 | 26.457 | 160.853 | 33.973 | 121.447 | 45.952 | 65.193 | 10.543 | 84.532 | 34.013 | 51.606 | 20.92 | 67.145 | 70.762 | 62.176 | 65.045 | 101.705 | 109.802 | 89.82 | 62.638 |
| Operating Income Ratio
| 0.171 | 0.204 | 0.15 | 0.034 | 0.206 | 0.104 | 0.009 | 0.001 | 0.045 | -0.025 | 0.166 | 0.023 | 0.219 | 0.158 | 0.28 | 0.186 | 0.766 | 0.087 | 0.249 | 0.109 | 0.252 | 0.119 | 0.174 | 0.036 | 0.244 | 0.115 | 0.181 | 0.081 | 0.249 | 0.263 | 0.271 | 0.263 | 0.378 | 0.451 | 0.327 | 0.313 |
| Total Other Income Expenses Net
| 40.013 | -9.225 | 0.144 | 15.445 | -1.007 | 25.128 | 30.64 | -3.373 | -0.603 | -6.825 | -1.231 | -1.227 | 0.766 | 2.751 | 3.974 | -20.144 | 268.667 | -12.337 | -12.08 | -13.347 | -7.01 | -15.936 | -9.002 | -3.21 | -3.541 | -3.745 | -1.433 | -29.09 | 16.071 | 12.446 | 28.674 | 4.992 | 8.697 | 16.801 | 30.402 | 4.39 |
| Income Before Tax
| 183.452 | 145.887 | 109.379 | 29.599 | 149.578 | 106.704 | 35.503 | -2.569 | 18 | -23.669 | 95.809 | 10.894 | 123.53 | 83.065 | 172.439 | 63.116 | 423.087 | 22.777 | 157.683 | 35.023 | 121.516 | 45.883 | 64.034 | 5.642 | 87.692 | 35.512 | 53.527 | 49.744 | 78.535 | 73.165 | 89.214 | 70.177 | 109.632 | 125.15 | 119.498 | 64.091 |
| Income Before Tax Ratio
| 0.219 | 0.192 | 0.15 | 0.072 | 0.205 | 0.136 | 0.067 | -0.004 | 0.044 | -0.035 | 0.164 | 0.021 | 0.217 | 0.155 | 0.279 | 0.174 | 0.761 | 0.075 | 0.244 | 0.113 | 0.252 | 0.119 | 0.171 | 0.019 | 0.253 | 0.12 | 0.188 | 0.193 | 0.291 | 0.272 | 0.389 | 0.283 | 0.408 | 0.514 | 0.435 | 0.32 |
| Income Tax Expense
| -7.289 | 20.522 | 13.437 | -9.204 | -2.967 | 13.068 | -12.438 | -38.546 | 15.467 | -30.649 | 16.536 | -25.976 | -6.845 | 17.233 | 25.956 | -28.109 | 54.475 | 10.8 | 28.411 | 3.495 | 11.603 | 11.824 | 13.695 | -13.437 | 5.948 | 14.443 | 11.895 | -2.265 | 15.034 | 13.226 | 13.884 | 9.974 | 13.865 | 16.258 | 16.496 | 9.159 |
| Net Income
| 192.278 | 125.807 | 98.141 | 43.34 | 156.387 | 96.91 | 51.397 | 42.614 | 2.533 | 6.98 | 83.679 | 36.214 | 131.77 | 67.338 | 147.746 | 92.533 | 370.029 | 13.325 | 130.473 | 32.279 | 111.207 | 35.634 | 51.702 | 19.059 | 81.087 | 23.884 | 42.789 | 54.3 | 66.347 | 61.531 | 75.55 | 60.444 | 95.985 | 109.129 | 103.239 | 55.404 |
| Net Income Ratio
| 0.229 | 0.165 | 0.134 | 0.105 | 0.214 | 0.124 | 0.097 | 0.06 | 0.006 | 0.01 | 0.143 | 0.069 | 0.231 | 0.125 | 0.239 | 0.255 | 0.666 | 0.044 | 0.202 | 0.104 | 0.231 | 0.092 | 0.138 | 0.064 | 0.234 | 0.08 | 0.15 | 0.21 | 0.246 | 0.229 | 0.329 | 0.244 | 0.357 | 0.448 | 0.376 | 0.277 |
| EPS
| 0.46 | 0.3 | 0.23 | 0.1 | 0.37 | 0.23 | 0.12 | 0.1 | 0.006 | 0.017 | 0.2 | 0.088 | 0.32 | 0.16 | 0.36 | 0.23 | 0.92 | 0.034 | 0.33 | 0.081 | 0.28 | 0.09 | 0.13 | 0.047 | 0.2 | 0.061 | 0.11 | 0.14 | 0.17 | 0.15 | 0.19 | 0.17 | 0.27 | 0.31 | 0.29 | 0.16 |
| EPS Diluted
| 0.46 | 0.3 | 0.23 | 0.1 | 0.37 | 0.23 | 0.12 | 0.1 | 0.006 | 0.017 | 0.2 | 0.088 | 0.32 | 0.16 | 0.35 | 0.23 | 0.91 | 0.034 | 0.32 | 0.081 | 0.28 | 0.09 | 0.13 | 0.047 | 0.2 | 0.061 | 0.11 | 0.14 | 0.17 | 0.15 | 0.19 | 0.17 | 0.27 | 0.31 | 0.29 | 0.16 |
| EBITDA
| 192.721 | 239.009 | 114.932 | 95.477 | 167.912 | 116.131 | 58.852 | 78.559 | 31.788 | -9.785 | 101.222 | 13.817 | 130.398 | 84.581 | 176.473 | 81.26 | 433.527 | 33.21 | 170.475 | 48.76 | 129.561 | 64.385 | 71.881 | 14.151 | 95.106 | 44.436 | 55.007 | 109.957 | 62.9 | 100.885 | 60.662 | 130.276 | 100.952 | 157.972 | 89.261 | 101.829 |
| EBITDA Ratio
| 0.23 | 0.314 | 0.157 | 0.232 | 0.23 | 0.148 | 0.111 | 0.11 | 0.078 | -0.015 | 0.173 | 0.026 | 0.229 | 0.158 | 0.285 | 0.224 | 0.78 | 0.109 | 0.263 | 0.157 | 0.269 | 0.166 | 0.192 | 0.048 | 0.275 | 0.15 | 0.193 | 0.426 | 0.233 | 0.376 | 0.264 | 0.526 | 0.376 | 0.648 | 0.325 | 0.509 |